Pharmaceutical companies are racing against the clock to meet the looming deadline set by the Trump administration to lower U.S.…
Browsing: drugmakers
The biotech industry is facing a challenging funding environment, with a 65% decrease in funding in the second quarter of…
Basel: A Global Life Sciences Hub Basel, Switzerland, has long been a magnet for life sciences companies, with its stable…
The pharmaceutical industry is facing uncertainty as President Donald Trump’s threats of imposing 200% tariffs and restrictive pricing policies loom…
The biopharma sector is experiencing a surge in job cuts this year, surpassing the numbers seen in 2024. By July…
A group of pharmaceutical companies have come together to form the IRA Watchdog, a coalition focused on analyzing the potential…
The Trump administration is taking steps to boost pharmaceutical manufacturing in the United States with the introduction of a new…
The recent unveiling of new healthcare policies by the Trump administration has sparked a major shift in favor of the…
Megablockbusters are becoming increasingly common in the pharmaceutical industry, with more drugs surpassing the $10 billion sales threshold than ever…
Antibody-drug conjugates (ADCs) were the highlight of this year’s annual meeting of the American Society of Clinical Oncology, sparking excitement…
